Structure Therapeutics American Stock Filter Stocks by Fundamentals
| GPCR Stock | 25.57 1.25 4.66% |
Fundamental analysis of Structure Therapeutics allows traders to better anticipate movements in Structure Therapeutics' stock price by examining its financial health and performance throughout various phases of its business cycle.
Structure | Shares Owned by Institutions | Build AI portfolio with Structure Stock |
Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Structure Therapeutics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Structure Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Structure Therapeutics' managers, analysts, and investors.Environmental | Governance | Social |
Structure Fundamentals
| Return On Equity | -0.19 | ||||
| Return On Asset | -0.14 | ||||
| Current Valuation | 591.56 M | ||||
| Shares Outstanding | 57.54 M | ||||
| Shares Owned By Insiders | 2.74 % | ||||
| Shares Owned By Institutions | 94.01 % | ||||
| Number Of Shares Shorted | 9.14 M | ||||
| Price To Book | 1.70 X | ||||
| EBITDA | (158.23 M) | ||||
| Net Income | (122.53 M) | ||||
| Total Debt | 3.86 M | ||||
| Book Value Per Share | 15.10 X | ||||
| Cash Flow From Operations | (116.64 M) | ||||
| Short Ratio | 7.91 X | ||||
| Earnings Per Share | (2.34) X | ||||
| Target Price | 78.86 | ||||
| Number Of Employees | 163 | ||||
| Beta | -1.79 | ||||
| Market Capitalization | 1.47 B | ||||
| Total Asset | 903.33 M | ||||
| Retained Earnings | (329.1 M) | ||||
| Working Capital | 855.19 M | ||||
| Net Asset | 903.33 M |
About Structure Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Structure Therapeutics American's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Structure Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Structure Therapeutics American based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Structure Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Structure Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Structure Stock
Moving against Structure Stock
The ability to find closely correlated positions to Structure Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Structure Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Structure Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Structure Therapeutics American to buy it.
The correlation of Structure Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Structure Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Structure Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Structure Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Structure Stock Analysis
When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.